Amplitude Surgical - Consolidated 9-Month Sales for FY 2023-24 of €79.6m, up +6.1% at Constant Exchange Rates

VALENCE, France--(BUSINESS WIRE)--Regulatory News: Amplitude Surgical (ISIN: FR0012789667, Mnemo: AMPLI, PEA-PME eligible), the French market leader in surgical technologies for lower limb orthopedics, announces its consolidated sales for the third quarter of the 2023-24 financial year. Olivier Jallabert, Chief Executive Officer of Amplitude Surgical, comments: "In the first 9 months of the 2023-24 financial year, Amplitude Surgical continued its growth trajectory, posting sales growth of +6.1%